Panagiota Anyfanti Selected Research

Fibronectins (Fibronectin)

1/2020

Chanzyme TRPM7 protects against cardiovascular inflammation and fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Panagiota Anyfanti Research Topics

Disease

12	Hypertension (High Blood Pressure) 01/2019 - 11/2011
8	Rheumatoid Arthritis 04/2024 - 07/2012
8	Inflammation (Inflammations) 10/2023 - 01/2011
7	Cardiovascular Diseases (Cardiovascular Disease) 05/2024 - 01/2018
6	Essential Hypertension 01/2020 - 01/2012
3	Atherosclerosis 01/2019 - 11/2017
3	Neoplasms (Cancer) 01/2012 - 01/2011
2	Thromboinflammation 10/2023 - 01/2022
2	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2022 - 01/2022
2	Vascular System Injuries 01/2022 - 12/2020
2	Thrombosis (Thrombus) 01/2022 - 01/2011
2	Masked Hypertension 01/2022 - 08/2014
2	Type 2 Diabetes Mellitus (MODY) 01/2020 - 01/2019
2	Microvascular Rarefaction 12/2019 - 08/2014
2	Fibrosis (Cirrhosis) 01/2019 - 01/2011
2	Sepsis (Septicemia) 11/2011 - 01/2011
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 05/2024
1	Systemic Vasculitis 05/2024
1	Carotid Artery Diseases 04/2024
1	Hyperglycemia 01/2020
1	Necrosis 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 01/2019
1	Vascular Diseases (Vascular Disease) 01/2018
1	Arthritis (Polyarthritis) 07/2016
1	Pain (Aches) 07/2016
1	Dyslipidemias (Dyslipidemia) 01/2016
1	Insulin Resistance 01/2016
1	Lymphoma (Lymphomas) 08/2015
1	Cardiomegaly (Heart Hypertrophy) 05/2014
1	White Coat Hypertension 03/2013
1	Hyperaldosteronism (Conn Syndrome) 01/2012
1	Vascular Remodeling 01/2012
1	Adenoma (Adenomas) 01/2012
1	Neoplasm Metastasis (Metastasis) 01/2011
1	Ischemia 01/2011
1	Neutropenia 12/2010

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2018
6	Retinaldehyde (Retinal)IBA 01/2019 - 03/2013
4	CytokinesIBA 01/2020 - 11/2011
3	AlbuminsIBA 01/2020 - 12/2018
3	AldosteroneIBA 01/2018 - 01/2012
2	Janus KinasesIBA 04/2024 - 12/2022
2	Antirheumatic Agents (DMARD)IBA 04/2024 - 12/2022
2	Janus Kinase InhibitorsIBA 04/2024 - 12/2022
2	Galectin 3 (LGALS3)IBA 10/2023 - 01/2019
2	InterleukinsIBA 01/2020 - 05/2014
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 11/2011
2	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 01/2018 - 06/2017
2	Antihypertensive Agents (Antihypertensives)IBA 04/2014 - 01/2012
2	Tumor Necrosis Factor InhibitorsIBA 05/2013 - 12/2010
1	Complement System Proteins (Complement)IBA 05/2024
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 05/2024
1	AutoantibodiesIBA 05/2024
1	Indicators and Reagents (Reagents)IBA 11/2022
1	Immunomodulating AgentsIBA 01/2021
1	CoagulantsIBA 12/2020
1	CollagenIBA 01/2020
1	Fibronectins (Fibronectin)IBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	Interleukin-12 (IL 12)IBA 01/2020
1	Oxygen (Dioxygen)IBA 12/2019
1	A-factor (Streptomyces)IBA 01/2019
1	Metformin (Glucophage)FDA LinkGeneric 01/2019
1	SaltsIBA 01/2018
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018
1	CholesterolIBA 06/2017
1	ametantrone (HAQ)IBA 07/2016
1	Insulin (Novolin)FDA Link 01/2016
1	C-Reactive ProteinIBA 01/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016
1	Radioisotopes (Radionuclides)IBA 08/2015
1	ClayIBA 05/2015
1	cardiotrophin 1IBA 05/2014
1	Angiotensin Receptor AntagonistsIBA 04/2014
1	tabalumabIBA 05/2013
1	Monoclonal AntibodiesIBA 05/2013
1	B-Cell Activating FactorIBA 07/2012
1	Tissue Inhibitor of Metalloproteinase-1IBA 01/2012
1	Tissue Inhibitor of Metalloproteinase-2IBA 01/2012
1	Matrix Metalloproteinases (MMPs)IBA 01/2012
1	SodiumIBA 01/2012
1	Metalloproteases (Metalloproteinases)IBA 01/2012
1	Interleukin-6 (Interleukin 6)IBA 01/2012
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2011
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2011
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 11/2011
1	Transcription Factors (Transcription Factor)IBA 11/2011
1	Proteinase-Activated ReceptorsIBA 01/2011
1	AnticoagulantsIBA 01/2011
1	Thrombin FDA Link 01/2011

Therapy/Procedure

3	Lasers (Laser) 11/2022 - 01/2021
3	Therapeutics 01/2020 - 11/2011
2	Sympathectomy (Sympathectomies) 05/2012 - 11/2011
1	Cell Transplantation 01/2019
1	Nephrectomy 01/2012
1	Immunomodulation 11/2011